Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. | Bull. W.H.O. (Print);76(1): 25-32, 1998. | WHOLIS

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

Berman, J. D.; Badaro, R.; Thakur, C. P.; Wasunna, K. M.; Behbehani, K.; Davidson, R.; Kuzoe, F.; Pang, L.; Weerasuriya, K.; Bryceson, A. D..

Bull. W.H.O. (Print) ; 76(1): 25-32, 1998.

Article in English | WHO IRIS | ID: who-260579

Responsible library: CH1.1

Research Article

Search on Google

Full text: Available Collection: Databases of international organizations Database: WHO IRIS Language: English Journal: Bull. W.H.O. (Print) Year: 1998 Document type: Article

Search on Google

Full text: Available Collection: Databases of international organizations Database: WHO IRIS Language: English Journal: Bull. W.H.O. (Print) Year: 1998 Document type: Article